Dynavax Technologies Corporation
DVAX
$10.31
-$0.34-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 27.31M | 20.48M | 17.18M | 9.22M | -6.39M |
| Total Depreciation and Amortization | 8.05M | 7.94M | 7.76M | 7.57M | 7.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.19M | 40.97M | 36.94M | 34.15M | 38.47M |
| Change in Net Operating Assets | -16.04M | -42.12M | -22.94M | 5.33M | 61.21M |
| Cash from Operations | 66.51M | 27.27M | 38.93M | 56.26M | 100.56M |
| Capital Expenditure | -6.35M | -4.60M | -3.60M | -3.57M | -4.10M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 1.00M | 1.00M | 1.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.68M | -57.05M | -149.65M | -96.19M | -150.82M |
| Cash from Investing | -18.04M | -61.64M | -152.25M | -98.76M | -153.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.29M | 7.71M | 8.46M | 9.42M | 7.90M |
| Repurchase of Common Stock | -109.31M | -9.07M | -9.31M | -9.15M | -6.51M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.02M | -1.37M | -848.00K | 273.00K | 1.39M |
| Foreign Exchange rate Adjustments | -862.00K | 577.00K | -91.00K | -28.00K | 324.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.40M | -35.17M | -114.26M | -42.26M | -51.66M |